An Open Label Phase 2 Study of ManNAc in Subjects With GNE Myopathy

NCT02346461 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

12

Enrollment

NIH

Sponsor class

Conditions

GNE Myopathy

Interventions

DRUG: ManNAc
DRUG: ManNAc

Sponsor

National Human Genome Research Institute (NHGRI)

Collaborators

[object Object]